Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.
Welcome to Advanced Practice Corner
A space created exclusively for advanced practice providers in oncology. Here, you’ll find a wealth of resources tailored to your needs, including insightful articles, event information, a comprehensive resource guide, and educational videos.
Our mission is to support your vital role in cancer care by providing the latest advances in therapy options, adverse effect management, and patient communication strategies. This is your hub for the tools and knowledge to enhance your expertise and empower your practice.
Latest News
Advertisement
Integrating PRO tools in survivorship care may help oncology nurses address ongoing emotional and physical needs of ovarian cancer survivors.
Here are 5 presentations oncology APPs should know about, from patient management to practice management.
The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings.
The FDA has approved ziftomenib for relapsed or refractory acute myeloid leukemia harboring NPM1 mutations with no alternative treatment options.
